Appian Provides New Digital Solution for Pharmacovigilance Reporting to Bayer
RESTON, Va. and FRANKFURT, Germany, June 28, 2018 (GLOBE NEWSWIRE) -- Appian (NASDAQ:APPN) today announced that Bayer's Pharmaceuticals division has selected the Appian application platform to digitize and optimize its processes for requesting internal reports on pharmacovigilance (PV) data.
Complex IT systems, deployed over decades, often work in isolation and support just a very little piece of a process landscape. They focus on the specialties of their data types but not on people, their collaboration and sequence of activities. People have to remember many rules and process steps when they combine data manually from different sources.
By focusing on people and their collaboration, solutions built on Appian help to accelerate business improvement while providing the flexibility to review, improve processes and rules continuously. Tracking Key Performance Indicators (KPIs) is an integral part of all process implementations, providing insights and visibility across the business.
Appian delivers the starting point and comprehensive insights into the operational processes for generating listings and aggregate statistics on side effects, their medical contents and processing efforts. Appian offers modern interfaces that are powerful yet easy to use.
Appian's solution automates recurring decisions based on rules and supports approvals from mobile devices when required. As a result, tasks can be completed more efficiently while spending more time on higher value activities.
"The pharmaceutical industry has realized that it needs to implement digital technologies to remain competitive and successful. Increasingly strict regulations, cost pressure, and rising patient expectations challenge organizations. They are only able to fulfill these demands if the processes used for implementing rules and regulations are being simplified and streamlined - thereby ensuring pharmaceutical companies' competitive edge," said Evi Cohen, VP of Global Pharmaceuticals and Life Sciences, Appian.
Appian provides a leading low-code software development platform that enables organizations to rapidly develop powerful and unique applications. The applications created on Appian's platform help companies drive digital transformation and competitive differentiation. For more information, visit www.appian.com .
For more press-related information, please contact:
Director of Media Relations
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
Juniper Networks24.4.2019 09:01:39 CEST | Pressemeddelelse
Colruyt Group Selects Juniper Networks to Support its Digital Transformation
ADC Therapeutics SA24.4.2019 07:02:02 CEST | Pressemeddelelse
ADC Therapeutics and Adagene Announce License Agreement
Bombardier Inc.23.4.2019 22:56:39 CEST | Pressemeddelelse
Media Advisory: Bombardier to Report its First Quarter 2019 Financial Results and to Hold its Annual Meeting of Shareholders on Thursday, May 2
INVNT23.4.2019 15:21:17 CEST | Pressemeddelelse
Continued Growth for INVNT Following Client Wins, An Expanded Offering, New Offices and Fresh Talent
Meizu Technology ltd23.4.2019 15:01:15 CEST | Pressemeddelelse
Always Powered by Passion: Meizu 16s Flagship Smartphone Unveiled, Snapdragon 855 and 48MP OIS Dual Camera
iGrafx23.4.2019 14:50:04 CEST | Pressemeddelelse
iGrafx Announces Cohesive RPA Accelerator Solution
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum